Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease

Journal of Cell Biology

Volumn 140, Issue 4, 1998, Pages 925-934

  Gow, Alexander ^a   Southwood, Cherie M ^a   Lazzarini, Robert A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN; PROTEOLIPID PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; MALE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ANIMALS; APOPTOSIS; CELL NUCLEUS; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; DISEASE MODELS, ANIMAL; GENE EXPRESSION; MICE; MICE, JIMPY; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MUTATION; MYELIN PROTEOLIPID PROTEIN; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; RNA, MESSENGER;

ANIMALIA; TRIXIS;

EID: 0032559544     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.140.4.925     Document Type: Article

References (71)

1. Barres, B.A., I.K. Hart, H.S. Coles, J.F. Burne, J.T. Voyvodic, W.D. Richardson, and M.C. Raff. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 70:31-46.
2. Billings-Gagliardi, S., L.H. Adcock, and M.K. Wolf. 1980. Hypomyelinated mutant mice: description of jpmsd and comparison with jp and qk on their present genetic backgrounds. Brain Res. 194:325-338.
3. Boespflug-Tanguy, O., C. Mimault, J. Melki, A. Cavagna, G. Giraud, D. Pham Dinh, B. Dastugue, A. Dautigny, and P.C. Group. 1994. Genetic homogeneity of Pelizaeus-Merzbacher disease: tight linkage to the proteolipoprotein locus in 16 affected families. Am. J. Hum. Genet. 55:461-467.
4. Boison, D., and W. Stoffel. 1994. Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc. Natl. Acad. Sci. USA. 91:11709-11713.
5. Cambi, F., X.M. Tang, P. Cordray, P.R. Fain, L.D. Keppen, and D.F. Barker. 1996. Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia. Neurology. 46:1112-1117.
6. Carango, P., V.L. Funanage, R.E. Ruben, C.S. Debruyn, and H.G. Marks. 1995. Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzbacher disease. Ann. Neurol. 38:610-617.
7. Dentinger, M.P., K.D. Barron, and C.K. Csiza. 1982. Ultrastructure of the central nervous system in a myelin deficient rat. J. Neurocytol. 11:671-691.
8. Ellison, J.A., and J. de Vellis. 1994. Platelet-derived growth factor receptor is expressed by cells in the early oligodendrocyte lineage. J. Neurosci. Res. 37: 116-128.
9. Fanarraga, M.L., I.R. Griffiths, M.C. McCulloch, J.A. Barrie, P.G. Kennedy, and P.J. Brophy. 1992. Rumpshaker: an X-linked mutation causing hypomyelination: developmental differences in myelination and glial cells between the optic nerve and spinal cord. Glia. 5:161-170.
10. Fanarraga, M.L., I.U. Sommer, I.R. Griffiths, P. Montague, N.P. Groome, K.-A. Nave, A. Schneider, P.J. Brophy, and P.G. Kennedy. 1993. Oligodendrocyte development and differentiation in the rumpshaker mutation. Glia. 9:146-156.
11. Garbern, J.Y., F. Cambi, X.-M. Tang, A.A.F. Sima, J.M. Vallet, E.P. Bosch, R. Lewis, M. Shy, J. Sohi, G. Kraft, et al. 1997. Proteolipid protein is necessary in peripheral as well as central myelin. Neuron. 19:205-218.
12. Ghandour, M., and R. Skoff. 1988. Expression of galactocerebroside in developing normal and jimpy oligodendrocytes in situ. J. Neurocytol. 17:485-498.
13. Gold, R., M. Schmied, G. Rothe, H. Zischler, H. Breitschopf, H. Wekerle, and H. Lassmann. 1993. Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. J. Histochem. Cytochem. 41:1023-1030.
14. Gow, A., and R.A. Lazzarini. 1996. A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat. Genet. 13:422-428.
15. Gow, A., V.L. Friedrich, Jr., and R.A. Lazzarini. 1994a. Intracellular transport and sorting of the oligodendrocyte transmembrane proteolipid protein. J. Neurosci. Res. 37:563-573.
16. Gow, A., V.L. Friedrich, Jr., and R.A. Lazzarini. 1994b. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J. Neurosci. Res. 37:574-583.
17. Gow, A., V.L. Friedrich, Jr., and R.A. Lazzarini. 1995. Apoptosis of myelin basic protein-positive oligodendrocytes in JIMPYMSD mice. J. Neurochem. 64:S44.
18. Gow, A., A. Gragerov, A. Gard, D.R. Colman, and R.A. Lazzarini. 1997. Conservation of topology, but not conformation, of the proteolipid proteins of the myelin sheath. J. Neurosci. 17:181-189.
19. Gravel, M., J. Peterson, V.W. Yong, V. Kottis, B. Trapp, and P.E. Braun. 1996. Overexpression of 2′.3′-cyclic nucleotide 3′-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol. Cell. Neurosci. 7:453-466.
20. Guthrie, S., and A. Pini. 1995. Chemorepulsion of developing motor axons by the floor plate. Neuron. 14:1117-1130.
21. Harding, B., D. Ellis, and S. Malcolm. 1995. A case of Pelizaeus-Merzbacher disease showing increased dosage of the proteolipid protein gene. Neuropathol. Appl. Neurobiol. 21:111-115.
22. Hodes, M., V. Pratt, and S. Dlouhy. 1993. Genetics of Pelizaeus-Merzbacher disease. Dev. Neurosci. 15:383-394.
23. Hodes, M.E., and S.R. Dlouhy. 1996. The proteolipid protein gene: double, double, ... and trouble. Am. J. Genet. 59:12-15.
24. Hudson, L.D., and N.L. Nadon. 1992. Amino acid substitutions in proteolipid protein that cause dysmyelination. In Myelin: Biology and Chemistry. R.E. Martenson, editor. CRC Press, Boca Raton, FL. 677-702.
25. Ikenaka, K., and T. Kagawa. 1995. Transgenic systems in studying myelin gene expression. Dev. Neurosci. 17:127-136.
26. Inoue, K., H. Osaka, N. Sugiyama, C. Kawanishi, H. Onishi, A. Nezu, K. Kimura, S. Kimura, Y. Yamada, and K. Kosaka. 1996a. A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR. Am. J. Genet. 59:32-39.
27. Inoue, Y., T. Kagawa, Y. Matsumura, K. Ikenaka, and K. Mikoshiba. 1996b. Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed eene dosage. Neurosci. Res. 25:161-172.
28. Johnson, G.D., R.S. Davidson, K.C. McNamee, G. Russell, D. Goodwin, and E.J. Holborow. 1982. Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. J. Immunol. Methods. 55:231-242.
29. Johnson, R.S., J.C. Roder, and J.R. Riordan. 1995. Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J. Neurochem. 64:967-976.
30. Kagawa, T., K. Ikenaka, Y. Inoue, S. Kuriyama, T. Tsujii, J. Nakao, K. Nakajima, J. Aruga, H. Okano, and K. Mikoshiba. 1994. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron. 13:427-442.
31. Klugmann, M., M.H. Schwab, A. Pullhofer, A. Schneider, F. Zimmermann, I.R. Griffiths, and K.-A. Nave. 1997. Assembly of CNS myelin in the absence of proteolipid protein. Neuron. 18:59-70.
32. Knapp, P., R. Skoff, and D. Redstone. 1986. Oligodendroglial cell death in jimpy mice: an explanation for the myelin deficit. J. Neurosci. 6:2813-2822.
33. Kobayashi, H., E. Hoffman, and H. Marks. 1994. The rumpshaker mutation in spastic paraplegia. Nat. Genet. 7:351-352.
34. Koeppen, A. 1992. Pelizaeus-Merzbacher disease: X-linked proteolipid protein deficiency in the human central nervous system. In Myelin: Biology and Chemistry. R. Martenson, editor. CRC Press, Boca Raton, FL. 703-721.
35. Macklin, W.B., B.D. Trapp, T. Kagawa, and K. Ikenaka. 1995. Hypomyelination in transgenic mice with multiple copies of the myelin proteolipid protein gene. J. Neurochem. 64:S86.
36. Mastronardi, F.G., C.A. Ackerley, L. Arsenault, B.I. Roots, and M.A. Moscarello. 1993. Demyelination in a transgenic mouse: a model for multiple sclerosis. J. Neurosci. Res. 36:315-324.
37. McKusick, V.A. 1994. Mendelian Inheritance in Man. (11th edition). Johns Hopkins University Press, Baltimore, MD. 3009 pp.
38. Milner, R., C. Lai, K. Nave, D. Lenoir, J. Ogata, and G. Sutcliffe. 1985. Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell. 42:931-939.
39. Mitchell, L.S., S.C. Gillespie, F. McAllister, M.L. Fanarraga, D. Kirkham, B. Kelly, P.J. Brophy, I.R. Griffiths, P. Montague, and P.G. Kennedy. 1992. Developmental expression of major myelin protein genes in the CNS of X-linked hvpomyelinating mutant rumpshaker. J. Neurosci. Res. 33:205-217.
40. Nadon, N.L., and I.D. Duncan. 1995. Gene expression and oligodendrocyte development in the myelin deficient rat. J. Neurosci. Res. 41:96-104.
41. Nadon, N.L., H. Arnheiter, and L.D. Hudson. 1994. A combination of PLP and DM20 transgenes promotes partial myelination in the jimpy mouse. J. Neurochem. 63:822-833.
42. Nishiyama, A., X.H. Lin, N. Giese, C.H. Heldin, and W.B. Stallcup. 1996. Colocalization of NG2 proteoglycan and PDGF α-receptor on O-2A progenitor cells in the developing rat brain. J. Neurosci. Res. 43:299-314.
43. Nussbaum, J.L., and G. Roussel. 1983. Immunocytochemical demonstration of the transport of myelin proteins through the Golgi apparatus. Cell Tiss. Res. 234:547-559.
44. Owen, C., and R.P. Skoff. 1995. Glial cells in myelin deficient jimpy mice in situ do not show increased DNA fragmentation compared with normals. J. Neurochem. 64:S63C.
45. Power, C., P. Kong, and B. Trapp. 1996. Major histocompatibility class I expression in oligodendrocytes induces hypomyelination in transgenic mice. J. Neurosci. Res. 44:165-173.
46. Puckett, C., L. Hudson, K. Ono, V. Friedrich, J. Benecke, M. Dubois-Dalcq, and R. Lazzarini. 1987. Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths. J. Neurosci. Res. 18:511-518.
47. Readhead, C., A. Schneider, I. Griffiths, and K.-A. Nave. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron. 12:583-595.
48. Rosenbluth, J., W. Stoffel, and R. Schiff. 1996. Myelin structure in proteolipid protein (PLP)-null mouse spinal cord. J. Comp. Neurol. 371:336-344.
49. Rosenfeld, J., and V.L. Freidrich, Jr. 1983. Axonal swellings in jimpy mice: does lack of myelin cause neuronal abnormalities? Neuroscience. 10:959-966.
50. Roussel, G., N. Meskovic, E. Trifilieff, J.-C. Artault, and J.-L. Nussbaum. 1987. Arrest of proteolipid transport through the Golgi apparatus in jimpy brain. J. Neurocytol. 16:195-204.
51. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Press, Cold Spring Harbor, NY.
52. Schneider, A., P. Montague, I. Griffiths, M. Fanarraga, P. Kennedy, P. Brophy, and K.-A. Nave. 1992. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature. 358:758-761.
53. Schneider, A., I. Griffiths, C. Readhead, and K.-A. Nave. 1995. Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc. Natl. Acad. Sci. USA. 92: 4447-4451.
54. Schwob, V.S., H.B. Clark, D. Agrawal, and H.C. Agrawal. 1985. Electron microscopic immunocytochemical localization of myelin proteolipid protein and myelin basic protein to oligodendrocytes in rat brain during myelination. J. Neurochem. 45:559-571.
55. Seitelberger, F. 1970. Pelizaeus-Merzbacher disease. In Handbook of Clinical Neurology: Leukodystrophies and Polydystrophies. Vol. 10. P. Vinken and G. Bruyn, editors. North-Holland, Amsterdam. 150-202.
56. Shamu, C.E., J.S. Cox, and P. Walter. 1994. The unfolded-protein-response pathway in yeast. Trends Cell Biol. 4:56-60.
57. Sistermans, E.A., I.J. de Wijs, R.F.M. de Coo, L.M.E. Smit, F.H. Menko, and B. A. van Oost. 1996. A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family. Hum. Genet. 97:337-339.
58. Skoff, R., and P. Knapp. 1992. Phenotypic expression of X-linked genetic defects affecting myelination. In Myelin: Biology and Chemistry. R. Martenson, editor. CRC Press, Boca Raton, FL. 653-676.
59. Skoff, R.P. 1995. Programmed cell death in the dysmyelinating mutants. Brain Pathol. 5:283-288.
60. Strable, U., P. Blader, J. Adam, and P.W. Ingham. 1994. A simple and efficient procedure for non-isotopic in situ hybridization to sectioned material. Trends Genet. 10:75-76.
61. Taraszewska, A., and I.B. Zelman. 1987. Electron microscopic study of glia in pt rabbit during myelination. Neuropatol. Pol. 25:351-368.
62. Tosic, M., A. Gow, M. Dolivo, K. Domanska-Janik, R.A. Lazzarini, and J.-M. Matthieu. 1996. Proteolipid/DM20 proteins bearing the paralytic tremor mutation in peripheral nerves and transfected COS-7 cells. Neurochem. Res. 21: 423-430.
63. Tosic, M., B. Matthey, A. Gow, R.A. Lazzarini, and J.-M. Matthieu. 1997. Intracellular transport of the DM-20 bearing shaking pup (shp) mutation and its possible phenotypic consequences. J. Neurosci. Res. 50:844-852.
64. Turnley, A.M., G. Morahan, H. Okano, O. Bernard, K. Mikoshiba, J. Allison, P.F. Bartlett, and J.A.F.P. Miller. 1991. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature. 353:566-569.
65. Watanabe, I., V. Patel, H.H. Goebel, A.N. Siakotos, W. Zeman, W. DeMyer, and J.S. Dyer. 1973. Early lesion of Pelizaeus-Merzbacher disease: electron microscopic and biochemical study. J. Neuropath. Exp. Neurol. 32:313-333.
66. Webster, H. deF, and N.H. Sternberger. 1980. Morphological features of myelin formation. In Neurological Mutations Affecting Myelination. N. Baumann, editor. Elsevier, Amsterdam. 73-86.
67. Williams, W.C., II, and A.L. Gard. 1995. DNA fragmentation is not a prominent feature of oligodendrocyte death in the jimpy mutant. J. Neurochem. 64:S98C.
68. Wu, Y., I. Whitman, E. Molmenti, K. Moore, P. Hippenmeyer, and D. Perlmutter. 1994. A lag in intracellular degradation of mutant α1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ α1-antitrypsin deficiency. Proc. Natl. Acad. Sci. USA. 91:9014-9018.
69. Yamamura, T., J.T. Konola, H. Wekerle, and M.B. Lees. 1991. Monoclonal antibodies against myelin proteolipid protein: identification and characterization of two major determinants. J. Neurochem. 57:1671-1680.
70. Yang, X., and R.P. Skoff. 1997. Proteolipid protein regulates the survival and differentiation of oligodendrocytes. J. Neurosci. 17:2056-2070.
71. Yoshioka, T., L. Feigenbaum, and G. Jay. 1991. Transgenic mouse model for central nervous system demyelination. Mol. Cell. Biol. 11:5479-5486.